Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Hypertension Monitoring in Glioma Patients Treated With Bevacizumab
This study has been terminated.
( Problems with enrollement of patients, less patients than expected )
Study NCT01046279 Information provided by University of Zurich
First Received on January 8, 2010. Last Updated on June 12, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glioma Patients
Additional conditions recognized in this trial
Glioma
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Vascular Diseases
Interventions listed in this trial
Bevacizumab
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of Zurich
Back to top of Main Content